Feed

29/11/2022
CMS ranked in Asi­a's Top 50 Largest Law Firms 2022
CMS has been ranked by Asi­an Leg­al Busi­ness (ALB) in the list of Asia’s Top 50 Largest Law Firms 2022. In the latest rank­ings, CMS is lis­ted as the 11th largest in­ter­na­tion­al firm in China and 31st largest...
28/11/2022
Over­view on the Ap­plic­a­tion for and Use of E-Busi­ness Li­censes
Nowadays, ap­plic­a­tion form­al­it­ies with the com­pet­ent Mar­ket Su­per­vi­sion Ad­min­is­tra­tion (the "MSA") and oth­er rel­ev­ant au­thor­it­ies such as tax bur­eaus have been gradu­ally sim­pli­fied and partly re­placed...
25/11/2022
New PRC Law on Pro­tec­tion of Rights and In­terests of Wo­men: Key Im­plic­a­tions...
China passed and ad­op­ted the newly amended PRC Law on Pro­tec­tion of Rights and In­terests of Wo­men (“New Law”) on 30 Oc­to­ber 2022. The New Law will come in­to force from 1 Janu­ary 2023 and aims to provide...
25/11/2022
CMS, China ranks in ten prac­tice areas in Leg­al 500 Asia Pa­cific
We are pleased to an­nounce that CMS, China con­tin­ues to be ranked and re­com­men­ded in ten areas in the Leg­al 500 Asia Pa­cific 2023 China edi­tion. We are re­cog­nised in the areas of An­ti­trust and Com­pet­i­tion...
24/11/2022
New PRC Law on Pro­tec­tion of Rights and In­terests of Wo­men: Key Im­plic­a­tions...
China passed and ad­op­ted the newly amended PRC Law on Pro­tec­tion of Rights and In­terests of Wo­men (“New Law”) on 30 Oc­to­ber 2022. The New Law will come in­to force from 1 Janu­ary 2023 and aims to provide...
23/11/2022
Chinese Tax Reg­u­la­tion Up­date | Oc­to­ber 2022
The latest de­vel­op­ment in China Tax Reg­u­la­tion mainly in­cludes: An­nounce­ment [2022] No. 33 jointly re­leased by the Min­istry of Fin­ance, the Gen­er­al Ad­min­is­tra­tion of Cus­toms and the State Ad­min­is­tra­tion...
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022 – re­cord­ings & present­a­tions
Un­cer­tain times, an evolving leg­al frame­work: man­aging risks and en­sur­ing so­cial re­spons­ib­il­ity in the life sci­ences & health­care sec­tor The risks of AI in the fu­ture of life sci­ences came un­der the mi­cro­scope at a land­mark leg­al For­um in Septem­ber.Health­care is ra­cing ahead in ad­opt­ing new tech­no­lo­gies across drug dis­cov­ery, de­vel­op­ment, man­u­fac­tur­ing and sup­ply chain but ex­perts pre­dict a tail-whip of dis­putes and con­tract fric­tion.Di­git­al trans­form­a­tion has the po­ten­tial to im­prove every as­pect of health­care and the pharma in­dustry but it also im­pacts data pro­tec­tion, IT se­cur­ity, con­tract design, li­ab­il­ity and reg­u­la­tion.The an­nu­al CMS Glob­al Life Sci­ences and Health­care For­um brought to­geth­er high-level in­dustry and leg­al ex­perts to dis­cuss sec­tor in­tel­li­gence and best prac­tice as well as is­sues ran­ging from cy­ber breaches and crypto­cur­rency wrangles to fall-outs over trade secrets and in­tel­lec­tu­al prop­erty (IP).“AI of­fers amaz­ing op­por­tun­it­ies to ad­vance life sci­ences and ush­er in trans­form­at­ive medi­cine such as cell and gene ther­apy, im­proved dia­gnostics and ana­lyt­ics but it also comes with con­cerns as leg­al and con­trac­tu­al risks are still be­ing un­der­stood and eval­u­ated,” says Nick Beck­ett, Glob­al Co-Head of CMS Life Sci­ences & Health­care Sec­tor Group“Sci­ence and tech­no­logy are mov­ing for­ward very quickly but we are find­ing that the de­tail and strategy of what to do to mit­ig­ate risks or re­solve them is lag­ging be­hind. These are crit­ic­ally im­port­ant is­sues that com­pan­ies need to ad­dress and the For­um ex­amined the im­plic­a­tions and solu­tions.”AI is boom­ing and a re­cent re­port by ana­lysts Grand View Re­search fore­cast that the glob­al AI in health­care mar­ket will grow from its cur­rent value of $10.4 bil­lion at a com­pound an­nu­al growth rate (CAGR) of 38.4% from 2022 to 2030. AI is fast be­com­ing a sig­ni­fic­ant ele­ment of every as­pect of health­care and leg­al de­part­ments and busi­ness units are be­ing chal­lenged to re­spond.The For­um, which was held in Brus­sels and on­line on Thursday, Septem­ber 29, had a packed agenda cov­er­ing tech­no­logy trans­form­a­tion, En­vir­on­ment­al, Sus­tain­ab­il­ity and Gov­ernance, sup­ply chain dis­rup­tion, reg­u­lat­ory frame­works and the chan­ging com­mer­cial land­scape.The scale of chal­lenge was evid­enced in the re­cent CMS Tech­no­logy Trans­form­a­tion: Man­aging Risks in a Chan­ging Land­scape re­port which re­vealed that 56% of cor­por­ate coun­sel and risk man­agers ex­pect an in­crease in AI-re­lated dis­putes, while 50% be­lieve that the use of AI tech­no­lo­gies will lead to risks and dis­putes that can­not cur­rently be fore­seen.Dis­putes will be driv­en by is­sues arising from IP and trade secrets, the use of AI, smart con­tracts, crypto­cur­ren­cies and cloud ser­vices, they be­lieve.“Or­gan­isa­tions are likely to see new types of risks and dis­putes emerge from the use of new tech­no­lo­gies such as AI and crypto­cur­ren­cies. Many busi­nesses are play­ing catch-up in un­der­stand­ing the risks as­so­ci­ated with these new tech­no­lo­gies,” says Lee Gluyas, Part­ner, CMS. “Whilst no busi­ness can elim­in­ate risks com­pletely, those that think ahead, plan early and act­ively man­age risk will give them­selves a sub­stan­tial ad­vant­age.”Fea­tured key­note speak­ers from the United Na­tions Health and De­vel­op­ment Team, gen­er­al coun­sel from lead­ing pharma com­pan­ies, Bo­ston Con­sult­ing Group, fin­an­cial ser­vices mul­tina­tion­al Aon and CMS sec­tor spe­cial­ists.
22/11/2022
Shang­hai Con­tin­ues En­cour­aging Headquarter En­ter­prises of Mul­tina­tion­al...
On Oc­to­ber 28, 2022, the People’s Gov­ern­ment of Shang­hai Mu­ni­cip­al­ity re­leased a No­tice on Is­su­ing the Re­vised Pro­vi­sions on En­cour­aging Mul­tina­tion­al Com­pan­ies to Es­tab­lish Re­gion­al Headquar­ters in...
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...
22/11/2022
Chinese Tax Reg­u­la­tion Up­date | Oc­to­ber 2022
The latest de­vel­op­ment in China Tax Reg­u­la­tion mainly in­cludes: An­nounce­ment [2022] No. 33 jointly re­leased by the Min­istry of Fin­ance, the Gen­er­al Ad­min­is­tra­tion of Cus­toms and the State Ad­min­is­tra­tion...
21/11/2022
Shang­hai Con­tin­ues En­cour­aging Headquarter En­ter­prises of Mul­tina­tion­al...
On Oc­to­ber 28, 2022, the People’s Gov­ern­ment of Shang­hai Mu­ni­cip­al­ity re­leased a No­tice on Is­su­ing the Re­vised Pro­vi­sions on En­cour­aging Mul­tina­tion­al Com­pan­ies to Es­tab­lish Re­gion­al Headquar­ters in...
09/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: The Life Sci­ences sec­tor...
The open­ing of COP27 has brought an in­tense glob­al fo­cus on cli­mate change and the tower­ing de­mands needed to reach car­bon net zero and to pro­tect the en­vir­on­ment. United Na­tions Gen­er­al Sec­ret­ary Ant­o­nio...